Navellier & Associates Inc Staar Surgical CO Transaction History

Navellier & Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$57.98 - $93.5 $318,310 - $513,315	-5,490 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $24,821 - $36,036	282 Added 5.41%	5,490 $501,000
Q3 2021 Oct 28, 2021	BUY	$122.75 - $162.68 $30,933 - $40,995	252 Added 5.08%	5,208 $669,000
Q2 2021 Aug 09, 2021	BUY	$105.76 - $154.96 $108,615 - $159,143	1,027 Added 26.14%	4,956 $756,000
Q1 2021 May 12, 2021	BUY	$78.5 - $126.48 $308,426 - $496,939	3,929 New	3,929 $414,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.